Furthermore, Resistin treatment dose-dependently increased the proportion of ALDH+ cells, a distinct breast cancer stem cell marker, along with enhanced stemness gene expression (SI Appendix, Fig. S9 A and B). The gene discussed is LDHA; the disease is breast carcinoma.